Tamsulosin Hydrochloride
Product Images NDC 84280-1201

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 84280-1201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by The Janz Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Tam Label)

Label for Tamsulosin Hydrochloride Capsules, USP 0.4 mg, manufactured by The Janz Corporation. The label states the product contains 500 capsules, includes storage instructions, dosage advisory to read prescribing information, and warnings about moisture and child safety. It displays the NDC number 84280-1201 and distributor address in Columbus, Ohio.*

FDA Label Image

Fig (Tamsulosin Fig 1)

A line graph showing the plasma concentration of Tamsulosin Hydrochloride over time in hours, comparing two conditions: fasted (dashed line) and fed (solid line). The y-axis represents plasma concentration in ng/mL, while the x-axis represents time in hours up to 36 hours.*

FDA Label Image

Fig (Tamsulosin Fig 2a)

A line graph showing mean change over duration of treatment in weeks for Tamsulosin Hydrochloride at doses 0.4 mg and 0.8 mg compared to placebo. The x-axis represents treatment duration from baseline to 13 weeks, with sample sizes noted. The y-axis indicates mean change values. The graph displays trends for each treatment group as distinct lines with markers: circles for 0.8 mg, triangles for 0.4 mg, and squares for placebo.*

FDA Label Image

Fig (Tamsulosin Fig 2b)

A line graph depicting the mean change in an unspecified measurement over 13 weeks of treatment with Tamsulosin Hydrochloride at dosages of 0.4 mg and 0.8 mg, compared to placebo. The x-axis represents duration of treatment in weeks, and the y-axis shows mean change. The graph includes data points at weeks 0, 1, 2, 5, 9, and 13, with sample sizes noted below each time point. Both dosages show a greater mean change than placebo over time.*

FDA Label Image

Fig (Tamsulosin Fig 3a)

A line graph depicting mean change in a variable measured in mL/sec over a duration of treatment in weeks. It compares three groups: 0.8 mg, 0.4 mg, and placebo, showing data points at baseline and multiple weeks up to 13 weeks. The graph includes sample sizes for each time point and uses different symbols to represent each treatment group.*

FDA Label Image

Fig (Tamsulosin Fig 3b)

A line graph depicting mean change in a measured variable (mL/sec) over treatment duration in weeks. The chart compares three groups: 0.8 mg dosage, 0.4 mg dosage, and placebo, represented by circle, triangle, and square markers respectively. Mean changes increase sharply early in the treatment and then level off.*

FDA Label Image

Str (Tamsulosin Str)

Chemical structure of Tamsulosin Hydrochloride showing its molecular components and arrangement, including aromatic rings and functional groups relevant to the active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.